Azficel-T

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAzficel-T
Drug Alias NameLaviv
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Fibroblast therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsNasolabial fold wrinklesCicatrixAcne Keloid +[4] 
Global Approved IndicationsNasolabial fold wrinkles
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/06/21
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFibrocell Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCastle Creek Biosciences LLC
Active IndicationsNasolabial fold wrinkles
Inactive IndicationsCicatrixAcne KeloidDysphonia

Other Information

ATC CodeV03AX
Related LinksKEGG